Actual bodyweight-adjusted dosing of argatroban provides "safe, effective" anticoagulation in obese patients

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1603, 2007-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dalteparin sodium dosages should be based on total or adjusted bodyweight in obese patients, rather than lean bodyweight

Inpharma, Vol. 1, Iss. 1254, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients

By Bartholomew John R.

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 489-499

Adis International

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Renal Anaemia in Children: No Justification for Bodyweight-Adjusted Dosage

By Port R.E.

Clinical Pharmacokinetics, Vol. 43, Iss. 1, 2004-01 ,pp. : 57-70

Adis International

Access to resources Recommend Favorite

Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use

By Cook Aaron M Whitlow Justin Hatton Jimmi Young Byron

Expert Opinion on Drug Safety, Vol. 8, Iss. 4, 2009-07 ,pp. : 411-419

Informa Healthcare

Access to resources Recommend Favorite

Rectal methohexital provides effective sedation for paediatric patients

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite